glp 1 news The GLP-1 revolution: What UAB researchers are discovering about how these drugs work GLP-1 drugs promise wider health

Olateju IV et al

Next, in Figure 2, we show rates of GLP-1 agonist use across different demographic groups defined by age and sex

If your experimental design doesnt account for enzymatic degradation, your results will be all over the place

Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis

l-Carnitine, an abundant nutrient in red meat, accelerates atherosclerosis in mice via gut microbiotadependent formation of trimethylamine (TMA) and trimethylamine N -oxide (TMAO) via a multistep pathway involving an atherogenic intermediate, -butyrobetaine (BB)

Research indicates that GHK-Cu may play a role in maintaining copper balance within neural environments, thereby contributing to cellular stability and signaling efficiency